SCHEMBL21757628

SCHEMBL21757628

O=CNC1CCCc2cnccc21

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.43
▸ TSHR P16473 1/20 0.43
▸ SIGMAR1 Q99720 1/20 0.41
▸ CHRNB2 P17787 1/20 0.40
▸ CHRNA4 P43681 1/20 0.40
▸ SCN1A P35498 1/20 0.39
▸ SCN5A Q14524 1/20 0.39
▸ SCN8A Q9UQD0 1/20 0.39
▸ MEN1 O00255 3/20 0.37
▸ KMT2A Q03164 3/20 0.37
▸ POLB P06746 2/20 0.37
▸ SMN1; SMN2 Q16637 2/20 0.37
▸ TAS1R3 Q7RTX0 1/20 0.36
▸ TAS1R1 Q7RTX1 1/20 0.36
▸ TAS1R2 Q8TE23 1/20 0.36
▸ JAK2 O60674 1/20 0.35
▸ JAK3 P52333 1/20 0.35
▸ GLA P06280 1/20 0.35
▸ MAPT P10636 1/20 0.35
▸ ALOX15 P16050 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24317225 0.91 CHRNB2 (0.36) ALDH1A1TSHRSIGMAR1CHRNB2CHRNA4
SCHEMBL17748985 0.80 CHRNB2 (0.46) ALDH1A1TSHRSIGMAR1CHRNB2CHRNA4
SCHEMBL6001031 0.78 HTT (0.55) ALDH1A1TSHRMEN1KMT2ASMN1; SMN2
SCHEMBL3532080 0.78 HTT (0.55) ALDH1A1TSHRMEN1KMT2ASMN1; SMN2
SCHEMBL3532081 0.78 HTT (0.55) ALDH1A1TSHRMEN1KMT2ASMN1; SMN2
SCHEMBL5051431 0.77 ALDH1A1 (0.53) ALDH1A1TSHRMEN1KMT2APOLB
SCHEMBL5051427 0.77 ALDH1A1 (0.53) ALDH1A1TSHRMEN1KMT2APOLB
SCHEMBL28175935 0.76 SIGMAR1 (0.44) ALDH1A1TSHRSIGMAR1CHRNB2CHRNA4
SCHEMBL14197875 0.76 CHRNB2 (0.43) ALDH1A1TSHRSIGMAR1CHRNB2CHRNA4
SCHEMBL24106055 0.73 EPHX1 (0.51) ALDH1A1MEN1KMT2ASMN1; SMN2TAS1R3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3215509-B1 SUBSTITUTED PYRROLO[1,2-A]PYRIMIDINES AND THEIR USE IN THE TREATMENT OF MEDICAL DISORDERS LYSOSOMAL THERAPEUTICS INC (US) 2020-02-26 — — EP disclosed
Send feedback